QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA
 |
BRISBANE, Australia, June 25, 2025 /PRNewswire/ --
More Articles ...
- Automation Anywhere Collaborates with Akshaya Patra to Power its Mission of Providing 5 million Daily Meals with Smarter AI Logistics
- BANNER S C (TULLIMBAR) PTY LTD ANNOUNCES OFFERING OF AUD 5,649,878 SENIOR SECURED LOAN NOTE OFFER
- Blue Whale Energy partners UNIGRID to deploy urban C I Battery storage across Southeast Asia
- UOB Asset Management anticipates a greater focus on Asian markets in 3Q 2025
- Dstny Group appoints Pieter Verstraeten as Chief Revenue Officer to accelerate sustainable growth
Health & Wellness
What Do Clinical Teams Need from Their Surgical Supply Partners?
Hashtag.net.au
In clinical settings, surgical supply partners aren’t just vendors. They sit quietly behind the scenes of operating lists, specialist consultations, treatment rooms and recovery workflows. When they...
The Growing Focus on Communication Development in Children
Hashtag.net.au
The early developmental years of a child's life represent a critical window for neurological growth, behavioural shaping, and language acquisition. During this formative phase, the ability to interpre...
Looking for a Family Dentist in Sydney? Here's What To Consider
Hashtag.net.au
Finding the right family dentist in Sydney is one of the most important health decisions you can make for your household. With hundreds of practices spread across the city — from Beecroft to Bondi, Pa...